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Abstract Large-scale expression of biopharmaceutical
proteins in cellular hosts results in production of large
insoluble mass aggregates. In order to generate functional
product, these aggregates require further processing
through refolding with denaturant, a process in itself that
can result in aggregation. Using a model folding protein,
cytochrome C, we show how an increase in final denaturant
concentration decreases the propensity of the protein to
aggregate during refolding. Using polarised fluorescence
anisotropy, we show how reduced levels of aggregation can
be achieved by increasing the period of time the protein
remains flexible during refolding, mediated through dilu-
tion ratios. This highlights the relationship between the
flexibility of a protein and its propensity to aggregate. We
attribute this behaviour to the preferential urea-residue
interaction, over self-association between molecules.
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Introduction
Biopharmaceutical production of therapeutic proteins
including hormones and monoclonal antibodies (Shukla
and Tho¨mmes 2010) is a rapidly expanding area of
research in biotechnology. However, the full benefits of
this technology are yet to be fully realised as there are a
number of barriers present in commercial production. One
of these barriers is that of protein aggregation, where non-
native protein monomers self-associate to form non-func-
tional macromolecules; aggregates. The presence of these
aggregates represents a loss of yield (and the cost of further
processing in removing them), and their presence in ther-
apeutics can trigger an immunogenic response, rendering
the treatment ineffective (Sauerborn et al. 2010). There-
fore, understanding the mechanisms of aggregation and
development of protocols for reduction of aggregation are
of high importance.
Post cellular production, quantities of the therapeutic
protein take the form of inclusion bodies; a high concen-
tration, insoluble mass aggregate of the recombinant pro-
tein that requires purification through refolding to obtain
functional protein. High concentrations of denaturant
(commonly urea) are required to solubilise the inclusion
bodies and unfold the high-molecular weight aggregates
(Basu et al. 2011). The preferential interaction (over that of
water) amongst urea, the protein backbone and side chain
groups are responsible for the unfolding of the aggregate at
high denaturant concentrations (Canchi and Garcı´a 2011;
Guinn et al. 2011). These interactions drive the equilibrium
of the protein towards the unfolded state with increasing
concentration of denaturant (Canchi et al. 2010). Whilst in
the presence of 8 M urea, it is possible that a protein still
maintains some semblance of its native structure, forming a
conformational space template for the protein to fold as
limited hydrophobic interactions may still remain (Shortle
and Ackerman 2001). Removal of the concentrated
denaturant drives the collapse of the protein via
hydrophobic and conformational backbone interactions
(Haran 2012), wherein the protein folds to a low energy
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state. Whilst hydrophobic collapse drives the formation of
the native state, the exposure of hydrophobic residues can
lead to aggregation of protein monomers in high concen-
tration environments (Fink 1998). Rapid refold dilution is
common practice to instigate hydrophobic collapse and
prevent hydrophobic exposure, however, Boismenu et al.
(1997) showed that a slow refold dilution is capable of
increasing refold yield significantly. Due to the time
dependent nature of the effect, we postulate this may be
attributed to mediation of late folding processes involved in
residue rearrangement and structural mobility; the molten
globule state, which occurs over a timescale of seconds
(Arai and Kuwajima 1996).
Using multiple stopped flow techniques, it is possible to
probe protein flexibility and investigate the role of final
denaturant concentration in refolding in terms of aggrega-
tion. Fluorescence anisotropy is an analytical technique
which offers the opportunity to probe the rotational
mobility of fluorophores within the protein molecule, and
provide information on their packing (Otto et al. 1994). It
has previously been used to probe the mobility of chaper-
one complexes (Weissman et al. 1996), whilst experiments
into refolding have clearly shown the existence of a molten
state during refolding (Canet et al. 2001) but its use in
relating this mobility to aggregation is novel. We combine
this with stopped flow absorbance measurements to mon-
itor aggregation during refolding. Here we present data for
cytochrome C, a protein which contains no disulphide
bonds, as a model system for biopharmaceuticals and show
that the existence of its molten globule during folding is
directly linked to its aggregation.
Materials and methods
All chemicals were supplied by Sigma Aldrich, UK
(reagent grade[99 % purity). Cytochrome C from bovine
heart was provided as lyophilised powder from Sigma
Aldrich, UK at [95 % purity as determined by SDS-
PAGE. The protein was solubilised in 100 mM TRIS pH
10.6 buffer and unfolded in 8 M reagent grade urea solu-
tion. Concentration values of unfolded cytochrome C were
produced at 1.6 9 10-3, 6.4 9 10-4 and 3.2 9 10-4 M as
determined by ultra-violet spectroscopy, and sample
absorbance at 320 nm was determined to be zero for each
sample, indicative of no high-molecular weight aggregates
being present from reconstitution (Murphy and Lee 2006).
In stopped flow experiments, refolding of each sample of
cytochrome C was initiated with dilution in 100 mM TRIS
pH 10.6. This is achieved using a dual channel mixing
system in the Applied Photophysics SX-20 in which a
syringe containing the denatured protein and one contain-
ing the refold buffer are simultaneously driven to achieve a
monodispersed mixing within a dead time of under 500 ls.
The stopped flow fluorescence anisotropy and absorbance
measurements were taken using the Applied Photophysics
SX-20 stopped flow fluorescence anisotropy accessory.
Hamilton syringes of 2.5 ml, 500, 250 and 100 ll were
installed to provide mixing ratios 1:25, 1:10, and 1:5. Final
concentrations for cytochrome C at each dilution was
6.4 9 10-5 M. Absorbance measurements were performed
in a 1 cm pathlength orientation at 320 nm. Anisotropy
measurements were performed by illuminating the sample
at 280 nm based on the instrument wavelength selector
coupled with a Schott UG-11 band pass filter on the inlet
channel for excitation coupled with analysis of emitted
light above 320 nm achieved with Schott WG-320 cut-off
filters on the polarised output channels. Results presented
are an average of at least 10 repeats.
The fluorescence anisotropy (r) is calculated using (1);
r ¼ IV  IH
IV þ 2IH ð1Þ
where the fluorescence anisotropy r is calculated from: Iv,
the fluorescence intensity of the vertically polarised emis-
sion and IH, the fluorescence intensity of the horizontally
polarised emission. High values of r relate to a more
stable fluorophores, and lower r values relate to fluo-
rophores which are more mobile (Steiner 1991).
Results and discussion
Refolding was initiated by the dilution of unfolded cyto-
chrome C in 8 M urea with TRIS refolding buffer. To
determine the effect of remaining urea concentration on the
aggregation of cytochrome C, stopped flow refolding was
performed at pH 10.6, marginally above the pI of the
protein (Malmgren et al. 1978). This was chosen in order to
prevent instability occurring from the solvation effects of
the buffer, and to reduce long range charge–charge inter-
action effects at extremes of pH (Ibarra-Molero et al.
1999), in order to ensure that the contribution from
unfolding is solely from the presence of the urea. Unfold-
ing was undertaken at three ratios (1:5, 1:10, 1:25) (Fig. 1).
The emergence of protein aggregates within the stopped
flow sample can be measured by the absorbance of light at
320 nm (Murphy and Lee 2006), where scattered light
from the aggregates manifests as an increase in intensity
related to growth in size or frequency of the aggregate
population.
The absorbance was observed to increase with time after
the initiation of refolding. The final absorbance was
greatest for the highest of the refold ratios (1:25), but lower
when the refold ratio was decreased, where a 1:5 refold
ratio results in a threefold decrease in absorbance over that
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of a 1:25 refold process (Fig. 1). As the mixing time occurs
well within the dead time of this experiment, it is evident
that aggregation is occurring in each of the dilution
experiments, where aggregation is more prevalent at higher
dilution ratios. The period over which the absorbance
plateaus differs between refold ratios. At high refold ratio,
the maximum value is achieved quickly, whilst at low
refold ratios the aggregation takes place over a longer time
period, taking circa five times longer to plateau. It is
postulated that the protracted time period for this process is
linked to the higher levels of urea concentration present in
the final buffer (1.33 M urea for the 1:5 refold ratio and
0.73 M for the 1:10) versus that for the highest refold ratio
(0.31 M for 1:25 refold ratio).
In order to probe the dynamics of this process, the
mobility of the protein was studied through examination of
the fluorescence anisotropy of cytochrome C at each refold
ratio. The anisotropy was measured using excitation at
280 nm, here the signal is dominated by the emission from
tryptophan residues. Bovine heart cytochrome C contains a
single tryptophan residue at the base of one of the a-helices
(2B4Z) (Berman et al. 2000). This residue, in combination
with the 4 tyrosines, is buried in the hydrophobic core of
the protein. Whilst the hydrophobic nature of the residues
may lead to reduce mobility due to rapid hydrophobic
collapse of the protein, any long term ([100 ms) mobility
within this residue may give an indication of the timescale
of side chain rearrangement in the latter stages of protein
folding.
There is a marked difference in anisotropy signal pro-
duced at each refold ratio (Fig. 1). At low refold ratio, the
change in anisotropy signal occurs over a 15-s time period,
whilst at 1:25 the change occurs within circa 5 s. This
indicates that at the lower refold ratios, cytochrome C
remains in a more flexible conformation (molten globule
state) than its native state for a longer period of time than at
higher dilution ratios. This timescale appears to be well
beyond the expected timescales attributed to hydrophobic
collapse and alpha helices formation in cytochrome C
(Akiyama et al. 2000, 2002), and in line with those
expected from the molten globule (Arai and Kuwajima
1996).
Results presented here indicate there is a correlation
between the flexibility of tryptophan side chain of cyto-
chrome C during folding, and its propensity to form
aggregates. At each refold ratio, the time period for side
chain mobility to cease and absorbance to plateau are
comparable. This change in anisotropy can be related to the
existence of the molten globule intermediate. Whilst the
protein is undergoing this transition in flexibility it is evi-
dent that aggregation is at its most prevalent. At increasing
refold ratios the time period over which this transition takes
place is reduced, a result which correlates with the
remaining concentration of urea in the sample. Signifi-
cantly, the increase in aggregation levels within the sample
take place within during the same time period as the
transition in flexibility, a result consistent for each refold
ratio. This indicates a relationship between the flexibility
within the protein, and its propensity to aggregate. Here,
we postulate that the transition in flexibility is indicative of





Fig. 1 Fluorescence anisotropy at 280 (diamond) and absorbance at
320 nm (solid line) of cytochrome C in 8 M urea refolded at 1:5 (a),
1:10 (b) and 1:25 (c) by dilution with 100 mM TRIS pH 10.6, to a
final protein concentration of 6.4 9 10-5 M
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As the protein contains a single tryptophan, this residue
may be responsible for the aggregation prone nature of the
partially unfolded protein as a whole, or it may be
indicative of the behaviour of other bulky hydrophobic side
chains within the protein which more probably contribute
to the aggregation of cytochrome C. The presence of urea
sustains the existence of the molten state, but reduces the
aggregation propensity of the molecule. We postulate that
the preferential interactions between urea and the
hydrophobic side chains prevent short-range attractive
interactions that would lead to self-association between
protein molecules and allow the hydrophobic residues to
adopt an orientation buried from the surface. However,
with lower the urea-side chain interactions present at
higher refold ratios due to the decrease in relative urea
concentration, the protein is forced to settle into a state
where the energetics from hydrophobic exposure are
instead reduced through association with a similarly per-
turbed aggregation prone molecule, resulting in aggregate
formation.
These findings are consistent with refolding literature
where the presence of moderate levels urea (1 M) will
suppress the aggregation of papain in an acid induced
molten globule state (Edwin et al. 2002) and that reducing
refold ratio will suppress aggregation during refolding by
dilution of recombinant protective antigen (Belton 2008).
In this latter work, it was postulated that a short-lived
molten globule intermediate was responsible for aggrega-
tion at higher refold ratios, but that reducing the refold ratio
suppressed aggregation as a result of higher final urea
concentrations. Here we have expanded upon these find-
ings to highlight the time dependent correlation between
protein flexibility and protein aggregation.
Overall, these findings indicate mediating the molten
globule state existence appears critical in keeping aggre-
gation levels low and thus maximising yield during the
refolding from solubilised inclusion bodies. Whilst further
work will examine the behaviour beyond the current model
refolding system of cytochrome C, current results indicate
that steps to elongate the existence of the molten globule,
such as stepwise refolding, could be crucial to reducing
aggregation during large-scale production of high value
proteins.
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